Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Emerge Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Designation or determination (6)
Australian public assessment report (AusPar) (5)
Prescription medicine registration (5)
Prescription medicine decision summary (3)
Cancellation by sponsor (2)

Date

2021 (1)
2020 (8)
2019 (8)
2017 (1)
2015 (2)
2014 (1)

Search

Sponsor content

21 result(s) found, displaying 21 to 21

REVASC Desirudin 15mg powder for injection vial and diluent ampoule Cancelled under s30(1)(c )

23 July 2014

Cancellation by sponsor

Requested by Emerge Health Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Product regulation

Safety and shortages

Resources and guidance

Business services

Emerge Health Pty Ltd

Type

Date

REVASC Desirudin 15mg powder for injection vial and diluent ampoule Cancelled under s30(1)(c )